TIS tissue therapies limited

vitrogro ecm meets ce mark requirements , page-31

  1. 2,276 Posts.
    lightbulb Created with Sketch. 95
    For those of you worried about a cap raising:-

    'The plan is to use revenue from EU sales to fund the rest of the world rollout including FDA trials, starting with the venous ulcer trial planned to start end of this year.'

    'The plan is to use EU sales revenue and so that is already public domain information'.

    So, for those of you suggesting a cap raise - that is NOT the plan. Self funding is a plan, and obviously depends on the sales success. I think most of us are very positive in this regard.

    The feedback was given to me by SM this evening and he gave me permission to pass it on as as far as he is concerned it is already public information.

    Regards...............

    Have a nice evening, enjoy the rest of the week and DYOR!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.